Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Brandi Z. Murrain
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

Knee Implant Manufacturer Agrees to $38.5 Million False Claims Act Settlement

Nov 18, 2025 | False Claims Act, Fraud Investigations, Health Care, Health Care Fraud, Medicare and Medicaid

On November 17, 2025, the DOJ announced that knee implant manufacturer Aesculap agreed to pay $38.5 million to resolve allegations under the False Claims Act (FCA) that it sold a knee-replacement device (the VEGA System Knee System) which it alleged the company knew...

Medical Device Manufacturer and Distributor Pay Combined $37 Million Under False Claims Act

Oct 5, 2025 | False Claims Act, Government Investigations, Health Care, Health Care Fraud, Medicare and Medicaid

On September 26, 2025, the Department of Justice announced that device manufacturer Semler Scientific had agreed to pay nearly $30 million, and its former distributor Bard Peripheral Vascular had agreed to pay an additional $7.2 million, in connection with the...

Knee Implant Manufacturer Agrees to $8 Million False Claims Act Settlement

Sep 17, 2025 | False Claims Act, Health Care, Health Care Fraud, Medicare and Medicaid

On September 16, 2025, the United States Attorney’s Office for the District of Maryland announced that knee implant manufacturer Exactech Inc. had agreed to pay $8 million to resolve allegations that it violated the False Claims Act (FCA). The press release...

HHS-OIG Expresses “Major Concerns” About Skin Substitutes

Sep 9, 2025 | Health Care, Health Care Fraud, Medicare and Medicaid

On September 8, 2025, the U.S. Department of Health & Human Services’ Office of Inspector General (HHS-OIG) issued a report expressing “major” fraud, waste, and abuse concerns related to skin substitutes billed to Medicare Part B. According to...

DOJ and State Medicaid Units Announce Massive Judgments Against Lab and Owners

Jul 17, 2025 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Health Care Fraud, Medicare and Medicaid

On July 17, 2025, the Department of Justice (DOJ) and the States of Colorado, Georgia, and South Carolina announced that the former CEO and owner of a now-defunct laboratory agreed to a consent judgment of over $27.5 million under the False Claims Act (FCA),...
Judge Imposes Nearly Billion Dollar False Claims Act Judgment Against CVS and Subsidiary

Judge Imposes Nearly Billion Dollar False Claims Act Judgment Against CVS and Subsidiary

Jul 13, 2025 | False Claims Act, Health Care, Health Care Fraud, Medicare and Medicaid

Back in December 2019, the United States Attorney’s Office for the Southern District of New York (USAO-SDNY) announced that it had filed a lawsuit under the False Claims Act (FCA) against CVS Health and its subsidiary, Omnicare, “for fraudulently billing...
« Older Entries
Next Entries »

Recent Posts

  • Kaiser Agrees to $556 Million False Claims Act Settlement
  • Skin Substitute Medicare Audits: Is Round Two on the Horizon?
  • South Carolina Laboratory Pleads Guilty and Settles False Claims Act Allegations
  • 2026 Brings Major Changes to Medicare’s Reimbursement Model for Skin Substitutes
  • Telehealth Company and Physician Owner Pay $300,000 To Resolve False Claims Act Liability Related to Excluded Provider

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Atlanta News
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Civil Rights
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • Defamation
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • Hemp & Cannabis
  • Hemp and Cannabis
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trade Law
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group